TTNP, DNDN and others on our watch list
As reported by Vinny Cassano Titan Pharmaceuticals (OTCBB:TTNP) provided quick resolution to the potentially troubling concerns of the prior weekend when the FDA indicated that it wanted to alter the Statistical Analysis Plan (SAP) for the completed Phase III Probuphine trial. {brmutility}Titan had filed the SAP with the FDA during the third quarter of 2010,
Profit from Insider Buying at Spar (SGRP), Alphatec (ATEC)
Insiders buy for one reason: they expect the stock to go up, so investors should follow this at Spar Group and Alphatec Holdings
Wednesday’s Small Cap Stocks to Watch (& What to Watch For): CLSN, BSDM, VHC
Small cap stocks Celsion Corporation (CLSN), VirnetX Holding Corporation (VHC), and BSD Medical Corporation (BSDM) are the ones you need to know about today. Here’s why.
Market Misperception May Offer Buying Opportunity for Pluristem
As reported by Ray Dirks Pluristem Therapeutics (Nasdaq: PSTI ) made a major announcement on Monday, June 20th, but that was a weak week for the Stock market, so PSTI is still way undervalued at $2.98. PSTI entered into an Exclusive License Agreement with United Therapeutics (UTHR.nasdaq) for the use of Pluristem’s Placental eXpanded (PLX) cells to develop and commercialize a cell-based product for the Treatment of Pulmonary Hypertension (PH). Under the terms of the Agreement,
Chinese Stocks (GURE, SINO, UTA) Falling will Drag Australian Stocks Down
Australia is tied to the Chinese Economy, with its stocks falling in tandem
Shipping Stocks Showing Takeover Volume (NEWL, EGLE, HRZ, TBSI, DHT)
This year is proving to be a record for mergers and activities with shipping stocks looking appealing for a number of factors/